Commissioning for menopause specialist services: A local perspective: An internet-based survey to assess the potential demand for menopause care in West Cheshire and the skills of local primary care clinicians in this field,with a view to informing future commissioning locally

Abstract

Objective

This study explores the perceived volume of women affected by peri- or post-menopausal issues that present to primary care clinicians in West Cheshire, plus the self-reported confidence of those clinicians in managing the menopause, and whether or not they feel that they and their patients should have access to a specialist menopause service.

Study design

Completion of an electronic survey.

Population

General practitioners and practice nurses working in West Cheshire.

Main outcome measure

To provide evidence for future local commissioning of menopause services.

Results

Ninety-one clinicians working within West Cheshire were sent an email request to complete the survey with 53 responses received (58%). The majority were general practitioners and were within the 35–54 year age range. The majority perceived that, each week in their clinical practice, they see between one and eight women who are affected by peri- or post-menopausal symptoms. Regarding their self-reported skills and knowledge in managing the menopause, almost half felt they had ‘good’ knowledge but ‘recognised (they) had learning needs’. Seven of the 53 (13%) felt their skills were ‘not good’. Two-thirds of those clinicians who completed the survey felt that they and their patients should have access to a specialist menopause service locally.

Conclusions

In the area covered by West Cheshire clinical commissioning group, there is no currently commissioned menopause service. This study has demonstrated that a substantial number of women present each week to clinicians working in this area who are felt to have peri- or post-menopausal symptoms. The clinicians have self-reported learning needs. Qualitative data from the survey would suggest training can be difficult to access. There is a clear need, both ethically and medically, for the commissioning of a West Cheshire specialist menopause service, with the proposed model being an integrated and holistic care model. Menopause care, and post-reproductive healthcare generally, provides an opportunity for collaboration and partnership working within an outcomes-based commissioning model. This study could be reviewed and replicated in other areas for comparison.

Keywords

Menopause postmenopause West Cheshire clinical commissioning group

Get full access to this article

View all access options for this article.

References

Bustreo

. Women’s health beyond reproduction: meeting the challenges. Bull World Health Organ 2012; 90: 478–478A.

British Menopause Society Council. Modernizing the NHS: observations and recommendations from the British Menopause Society. Menopause Int 2011; 17: 41–43.

NHS health check best practice guidance. London: Department of Health, Public Health England, September, 2013.

Morris

Currie

. Menopause international. Note from the editors: change is afoot. Menopause Int 2010; 16: 1.

Rossouw

Anderson

Prentice

. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 2002; 288: 321–333.

Million Women Study Collaborators. Breast cancer and HRT in the million women study. Lancet 2003; 362: 419–427.

Shapiro

Farmer

Seaman

. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 1. The collaborative reanalysis. J Fam Plann Reprod Health Care 2011; 37: 103–109.

Shapiro

Farmer

Mueck

. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 2. The women’s health initiative: estrogen plus progestogen. J Fam Plann Reprod Health Care 2011; 37: 165–172.

Shapiro

Farmer

Mueck

. Does Hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3.The women’s health initiative: unopposed estrogen. J Fam Plann Reprod Health Care 2011; 37: 225–230.

10.

Shapiro

Farmer

Stevenson

. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 4.The million women study. J Fam Plann Reprod Health Care 2012; 38: 102–109.

11.

Shapiro

Farmer

Stevenson

. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 5. Trends in breast cancer incidence in relation to the use of HRT. J Fam Plann Reprod Health Care 2013; 39: 80–88.

12.

Fenton

Panay

. The women’s health initiative – a decade of progress. Climacteric 2012; 15: 205.

13.

Hodis

Mack

. A ‘window of opportunity’: the reduction of coronary heart disease and total mortality with menopause therapies is age- and time-dependent. Brain Res 2011; 1379: 244–252.

14.

The Five Year Forward View, NHS England/Public Health England etc., October 2014.

15.

Naylor

. Transforming our health care system-ten priorities for commissioners [Revised Edition], London: The King's fund, April, 2015.

16.

Panay

Ferguson

. The ‘window of opportunity’ – should we be taking it?’. Climacteric 2014; 17: 211–212.

17.

Personal Social Services Research Unit. In: Curtis L, et al. (eds) Unit costs of health and social care, University of Kent, 2014.

18.

Mehra

. Reinventing the general practitioner menopause clinic-personal experiences. Post Reprod Health 2014; 20: 117–118.

19.

NHS Confederation Briefing. Beginning with the end in mind. How outcomes-based-commissioning can help unlock the potential of community services, London: NHS Confederation Briefing, September 2014.